Labetalol Hydrochloride
- Product NDC
- 70518-1163
- 11-digit product format
- 705181163
- Labeler code
- 70518
- Product ID
- 70518-1163_e314bfc0-9156-0ecd-e053-2a95a90ad774
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA207743
- Marketing category
- ANDA
- Marketing start
- 2018-05-11
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1163-0 | 70518116300 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1163-0) | 2018-05-11 | 0000-00-00 | No | No | Current |
| 70518-1163-1 | 70518116301 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1163-1) | 2018-07-23 | 0000-00-00 | No | No | Current |
| 70518-1163-2 | 70518116302 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1163-2) | 2021-01-12 | 0000-00-00 | No | No | Current |